Knut Schäkel, MD | Germany
2026
Knut
Schäkel
,
MD
Heidelberg University Hospital
Intercepting Psoriasis at the Earliest Stages: Lessons from STEP-IN and GUIDE
Featured Experts
Related Resources
What's New
Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
Tuesday, June 23, 2026
Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Monday, June 22, 2026
Videos Now Available from the IPC Symposium at SID Chicago
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Wednesday, June 17, 2026
Take Ten: Mio Nakamura – Psoriasis and Mental Health
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.